日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

HTATSF1 regulates innate antiviral immune response by orchestrating TRAF3-IRF3 and TRAF6-NF-κB pathways.

HTATSF1 通过协调 TRAF3-IRF3 和 TRAF6-NF-κB 通路来调节先天性抗病毒免疫反应。

Zeng Jia-Qing, Ruan Zi-Lun, Zhang Qi, Yi Xue-Mei, Chen Yun-Da, Hu Ming-Ming, Li Shu

The conserved poxvirus membrane entry-fusion apparatus component OPG147 targets MITA/STING for immune evasion.

痘病毒膜进入融合装置保守组分OPG147靶向MITA/STING以逃避免疫

Yi Xue-Mei, Li Mi, Wang Su-Yun, Wang Shi-Han, Zeng Jia-Qing, Lei Ya-Li, Zhang Yu, Zhu Chun-Yu, Zhang Ying, Song Jun-Hui, Chen Yun-Da, Wang Yun, Shu Hong-Bing, Li Shu, Wang Yan-Yi

Symptom experiences of cancer-related cognitive impairment in women with ovarian cancer

卵巢癌女性癌症相关认知障碍的症状体验

Wang, Liying; Ding, Yan; Zhang, Yi; Xue, Mei; Lu, Zhenqi; Zhang, Xiaoju

Programmed cell death receptor 1 inhibitor Pembrolizumab in the treatment of advanced gastric cancer

程序性死亡受体1抑制剂帕博利珠单抗治疗晚期胃癌

Yi, Xue-Mei; Cai, Hong-Qiao; Jiao, Yan

Activation of the PERK-CHOP signaling pathway during endoplasmic reticulum stress contributes to olanzapine-induced dyslipidemia

内质网应激期间 PERK-CHOP 信号通路的激活是奥氮平诱发血脂异常的原因之一。

Lu Liu ,Lei Tang ,Jia-Ming Luo ,Si-Yu Chen ,Chun-Yan Yi ,Xue-Mei Liu ,Chang-Hua Hu

The monkeypox virus-host interplays

猴痘病毒与宿主的相互作用

Yi, Xue-Mei; Lei, Ya-Li; Li, Mi; Zhong, Li; Li, Shu

Drug Survival Outcomes Associated with the Real-World Use of Ixekizumab, Secukinumab, Guselkumab, and Adalimumab for the Treatment of Plaque Psoriasis in China: A 52-Week Single-Center Retrospective Study

在中国,一项为期52周的单中心回顾性研究探讨了伊克珠单抗、司库奇尤单抗、古塞库单抗和阿达木单抗在真实世界中治疗斑块状银屑病的药物生存结局。

Li, Ying; Lu, Jia-Jing; Zhong, Xiao-Yuan; Yu, Ying-Yuan; Yu, Ning; Wang, Yu; Yi, Xue-Mei; Ding, Yang-Feng; Shi, Yu-Ling

Signaling and functions of interleukin-33 in immune regulation and diseases

白细胞介素-33在免疫调节和疾病中的信号传导和功能

Yi, Xue-Mei; Lian, Huan; Li, Shu